Advances in Bladder Cancer Immunotherapy, with Dr. Arjun Balar

Bladder cancer patients in the U.S. have seen a number of recent FDA approvals of different immunotherapies to treat the disease.

In this webinar for patients and caregivers, Dr. Arjun Balar of the NYU Langone Medical Center in New York, NY, discusses the latest research and developments in bladder cancer immunotherapy. This webinar was recorded Friday, May 19, 2017.

The "Cancer Immunotherapy and You" webinar series is produced by the Cancer Research Institute and is made possible with generous support from Bristol-Myers Squibb, Genentech, Regeneron, and Advaxis.

Join our email list for updates on cancer immunotherapy research, events, and opportunities to get involved with the Cancer Research Institute. Sign up below and be a force for change in the fight against cancer.

Join CRI in Shaping the Future of Immunotherapy

Support the pioneering work of CRI in advancing immunotherapy.

Father and son